The Schall Law Firm Seeks Investor Participation In A Securities Fraud Case Against Moderna, Inc.Accesswire • 09/12/24
Shareholders That Lost Money on Moderna, Inc. (MRNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 09/12/24
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ModernaPRNewsWire • 09/12/24
MRNA Stockholders Have Opportunity to Lead Moderna, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!Accesswire • 09/12/24
Moderna slashes research spending, trims pipeline as it looks to regain footingMarket Watch • 09/12/24
Moderna To Slash $1.1 Billion From R&D Spending In Major Commercial PushInvestors Business Daily • 09/12/24
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid futureCNBC • 09/12/24
Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRNAPRNewsWire • 09/12/24
Contact Levi & Korsinsky by October 8, 2024 Deadline to Join Class Action Against Moderna, Inc.(MRNA)GlobeNewsWire • 09/11/24
Moderna Inc Is Being Sued For Violating Securities Regulations And Stockholders Are Urged To Help The Schall Law FirmAccesswire • 09/11/24
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines – MRNAAccesswire • 09/11/24
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Moderna, Inc. (MRNA) ShareholdersAccesswire • 09/11/24
MRNA Shareholders Have Opportunity to Lead Moderna, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!Accesswire • 09/11/24
October 8, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRNAGlobeNewsWire • 09/10/24
The Schall Law Firm Encourages Investors To Partake In A Securities Fraud Case Against Moderna, Inc.Accesswire • 09/10/24
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune DiseasesPRNewsWire • 09/10/24
MRNA Investors Have Opportunity to Lead Moderna, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!Accesswire • 09/10/24
October 8, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRNAAccesswire • 09/09/24
Levi & Korsinsky Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 – MRNAAccesswire • 09/09/24